Pigs with APP have less mortality, fewer lung lesions after treatment with Excede® for Swine compared to enrofloxacin
4 August 2021
6 minute read
By: 
| References | ||||
|---|---|---|---|---|
| 1 Data on file, Study Report No. ORPORK 2030, Zoetis LLC. | ||||
| 2 Actinobacillus pleuropneumoniae in swine. Iowa State University. | ||||
| 3 Data on file, Study Report No. ORPORK 2030, Zoetis LLC. | ||||
| 4 Finch M, et al. Evaluation of the efficacy of ceftiofur crystalline free acid versus autogenous vaccination for control of Streptococcus suis and Haemophilus parasuis in a commercial swine production system. Am Assoc Swine Vet. 2019. | ||||
| 5 Hibbard B, et al. Pharmacokinetics of ceftiofur crystalline free acid in swine. Proceedings of the 18th IPVS Congress, Hamburg, Germany 2004, Volume 2. | ||||
| 6 Sweeney M, et al. Antimicrobial susceptibility of Actinobacillus pleuropneumoniae, Pasteurella multocida, Streptococcus suis, and Bordetella bronchiseptica isolated from pigs in the United States and Canada, 2011 to 2015. J Swine Health Prod. 2017;25(3):106-120. | ||||
